Cargando…
Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study
BACKGROUND: Until now, most of the research addressing long-term humoral responses in coronavirus disease 2019 (COVID-19) had only evaluated the serum titers of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgGs, without the assessment of the baseline antiviral clinical and immun...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421299/ https://www.ncbi.nlm.nih.gov/pubmed/36045688 http://dx.doi.org/10.3389/fimmu.2022.943563 |
_version_ | 1784777561923911680 |
---|---|
author | Torres-Ruiz, Jiram Lomelín-Gascón, Julieta Vargas-Castro, Ana Sofía Lira-Luna, Jaquelin Pérez-Fragoso, Alfredo Tapia-Conyer, Roberto Nuñez-Aguirre, Miroslava Alcalá-Carmona, Beatriz Absalón-Aguilar, Abdiel Maravillas-Montero, José Luis Mejía-Domínguez, Nancy Raquel Núñez-Álvarez, Carlos Rull-Gabayet, Marina Llorente, Luis Romero-Ramírez, Sandra Sosa-Hernández, Victor Andrés Cervantes-Díaz, Rodrigo Juárez-Vega, Guillermo Meza-Sánchez, David Eduardo Martínez-Juárez, Luis Alberto Morales-Juárez, Linda López-López, Lizeth Naomi Negrete-Trujillo, José Adrián Falcón-Lezama, Jorge Abelardo Valdez-Vázquez, Rafael Ricardo Gallardo-Rincón, Héctor Gómez-Martín, Diana |
author_facet | Torres-Ruiz, Jiram Lomelín-Gascón, Julieta Vargas-Castro, Ana Sofía Lira-Luna, Jaquelin Pérez-Fragoso, Alfredo Tapia-Conyer, Roberto Nuñez-Aguirre, Miroslava Alcalá-Carmona, Beatriz Absalón-Aguilar, Abdiel Maravillas-Montero, José Luis Mejía-Domínguez, Nancy Raquel Núñez-Álvarez, Carlos Rull-Gabayet, Marina Llorente, Luis Romero-Ramírez, Sandra Sosa-Hernández, Victor Andrés Cervantes-Díaz, Rodrigo Juárez-Vega, Guillermo Meza-Sánchez, David Eduardo Martínez-Juárez, Luis Alberto Morales-Juárez, Linda López-López, Lizeth Naomi Negrete-Trujillo, José Adrián Falcón-Lezama, Jorge Abelardo Valdez-Vázquez, Rafael Ricardo Gallardo-Rincón, Héctor Gómez-Martín, Diana |
author_sort | Torres-Ruiz, Jiram |
collection | PubMed |
description | BACKGROUND: Until now, most of the research addressing long-term humoral responses in coronavirus disease 2019 (COVID-19) had only evaluated the serum titers of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgGs, without the assessment of the baseline antiviral clinical and immune profile, which is the aim of this study and may be the key factor leading to a broad and sustained antibody response. METHODS: We included 103 patients with COVID-19. When the patients sought medical attention (baseline), a blood sample was drawn to perform immunophenotype of lymphocytes by flow cytometry. The patients were assessed 15 days after baseline and then every month until the third month, followed by a last visit 6 months after recruitment. We evaluated the anti-SARS-COV-2 IgG at all time points, and the serum levels of cytokines, chemokines, anti-cellular (AC) antibodies and neutrophil extracellular traps were also assessed during the follow-up. The primary outcome of the study was the presence of a sustained immune humoral response, defined as an anti-SARS-CoV-2 IgG titer >4.99 arbitrary units/mL in at least two consecutive measures. We used generalized lineal models to assess the features associated with this outcome and to assess the effect of the changes in the cytokines and chemokines throughout time on the development of a sustained humoral immune response. RESULTS: At baseline the features associated to a sustained immune humoral response were the diagnosis of critical disease, absolute number of lymphocytes, serum IP-10, IL-4, IL-2, regulatory T cells, CD8(+) T cells, and positive AC antibodies. Critical illness and the positivity of AC antibodies were associated with a sustained humoral immune response after 3 months, whilst critical illness and serum IL-13 were the explanatory variables after 6 months. CONCLUSION: A sustained immune humoral response is strongly related to critical COVID-19, which is characterized by the presence of AC antibodies, quantitative abnormalities in the T cell compartment, and the serum cytokines and chemokines during acute infection and throughout time. |
format | Online Article Text |
id | pubmed-9421299 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94212992022-08-30 Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study Torres-Ruiz, Jiram Lomelín-Gascón, Julieta Vargas-Castro, Ana Sofía Lira-Luna, Jaquelin Pérez-Fragoso, Alfredo Tapia-Conyer, Roberto Nuñez-Aguirre, Miroslava Alcalá-Carmona, Beatriz Absalón-Aguilar, Abdiel Maravillas-Montero, José Luis Mejía-Domínguez, Nancy Raquel Núñez-Álvarez, Carlos Rull-Gabayet, Marina Llorente, Luis Romero-Ramírez, Sandra Sosa-Hernández, Victor Andrés Cervantes-Díaz, Rodrigo Juárez-Vega, Guillermo Meza-Sánchez, David Eduardo Martínez-Juárez, Luis Alberto Morales-Juárez, Linda López-López, Lizeth Naomi Negrete-Trujillo, José Adrián Falcón-Lezama, Jorge Abelardo Valdez-Vázquez, Rafael Ricardo Gallardo-Rincón, Héctor Gómez-Martín, Diana Front Immunol Immunology BACKGROUND: Until now, most of the research addressing long-term humoral responses in coronavirus disease 2019 (COVID-19) had only evaluated the serum titers of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgGs, without the assessment of the baseline antiviral clinical and immune profile, which is the aim of this study and may be the key factor leading to a broad and sustained antibody response. METHODS: We included 103 patients with COVID-19. When the patients sought medical attention (baseline), a blood sample was drawn to perform immunophenotype of lymphocytes by flow cytometry. The patients were assessed 15 days after baseline and then every month until the third month, followed by a last visit 6 months after recruitment. We evaluated the anti-SARS-COV-2 IgG at all time points, and the serum levels of cytokines, chemokines, anti-cellular (AC) antibodies and neutrophil extracellular traps were also assessed during the follow-up. The primary outcome of the study was the presence of a sustained immune humoral response, defined as an anti-SARS-CoV-2 IgG titer >4.99 arbitrary units/mL in at least two consecutive measures. We used generalized lineal models to assess the features associated with this outcome and to assess the effect of the changes in the cytokines and chemokines throughout time on the development of a sustained humoral immune response. RESULTS: At baseline the features associated to a sustained immune humoral response were the diagnosis of critical disease, absolute number of lymphocytes, serum IP-10, IL-4, IL-2, regulatory T cells, CD8(+) T cells, and positive AC antibodies. Critical illness and the positivity of AC antibodies were associated with a sustained humoral immune response after 3 months, whilst critical illness and serum IL-13 were the explanatory variables after 6 months. CONCLUSION: A sustained immune humoral response is strongly related to critical COVID-19, which is characterized by the presence of AC antibodies, quantitative abnormalities in the T cell compartment, and the serum cytokines and chemokines during acute infection and throughout time. Frontiers Media S.A. 2022-08-15 /pmc/articles/PMC9421299/ /pubmed/36045688 http://dx.doi.org/10.3389/fimmu.2022.943563 Text en Copyright © 2022 Torres-Ruiz, Lomelín-Gascón, Vargas-Castro, Lira-Luna, Pérez-Fragoso, Tapia-Conyer, Nuñez-Aguirre, Alcalá-Carmona, Absalón-Aguilar, Maravillas-Montero, Mejía-Domínguez, Núñez-Álvarez, Rull-Gabayet, Llorente, Romero-Ramírez, Sosa-Hernández, Cervantes-Díaz, Juárez-Vega, Meza-Sánchez, Martínez-Juárez, Morales-Juárez, López-López, Negrete-Trujillo, Falcón-Lezama, Valdez-Vázquez, Gallardo-Rincón and Gómez-Martín https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Torres-Ruiz, Jiram Lomelín-Gascón, Julieta Vargas-Castro, Ana Sofía Lira-Luna, Jaquelin Pérez-Fragoso, Alfredo Tapia-Conyer, Roberto Nuñez-Aguirre, Miroslava Alcalá-Carmona, Beatriz Absalón-Aguilar, Abdiel Maravillas-Montero, José Luis Mejía-Domínguez, Nancy Raquel Núñez-Álvarez, Carlos Rull-Gabayet, Marina Llorente, Luis Romero-Ramírez, Sandra Sosa-Hernández, Victor Andrés Cervantes-Díaz, Rodrigo Juárez-Vega, Guillermo Meza-Sánchez, David Eduardo Martínez-Juárez, Luis Alberto Morales-Juárez, Linda López-López, Lizeth Naomi Negrete-Trujillo, José Adrián Falcón-Lezama, Jorge Abelardo Valdez-Vázquez, Rafael Ricardo Gallardo-Rincón, Héctor Gómez-Martín, Diana Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study |
title | Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study |
title_full | Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study |
title_fullStr | Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study |
title_full_unstemmed | Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study |
title_short | Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study |
title_sort | clinical and immunological features associated to the development of a sustained immune humoral response in covid-19 patients: results from a cohort study |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421299/ https://www.ncbi.nlm.nih.gov/pubmed/36045688 http://dx.doi.org/10.3389/fimmu.2022.943563 |
work_keys_str_mv | AT torresruizjiram clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT lomelingasconjulieta clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT vargascastroanasofia clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT liralunajaquelin clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT perezfragosoalfredo clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT tapiaconyerroberto clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT nunezaguirremiroslava clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT alcalacarmonabeatriz clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT absalonaguilarabdiel clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT maravillasmonterojoseluis clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT mejiadomingueznancyraquel clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT nunezalvarezcarlos clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT rullgabayetmarina clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT llorenteluis clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT romeroramirezsandra clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT sosahernandezvictorandres clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT cervantesdiazrodrigo clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT juarezvegaguillermo clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT mezasanchezdavideduardo clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT martinezjuarezluisalberto clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT moralesjuarezlinda clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT lopezlopezlizethnaomi clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT negretetrujillojoseadrian clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT falconlezamajorgeabelardo clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT valdezvazquezrafaelricardo clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT gallardorinconhector clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy AT gomezmartindiana clinicalandimmunologicalfeaturesassociatedtothedevelopmentofasustainedimmunehumoralresponseincovid19patientsresultsfromacohortstudy |